Retraction Note: Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients
- PMID: 39966704
- PMCID: PMC11837397
- DOI: 10.1186/s12872-025-04554-6
Retraction Note: Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients
Retraction of
-
Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients.BMC Cardiovasc Disord. 2024 Dec 19;24(1):710. doi: 10.1186/s12872-024-04376-y. BMC Cardiovasc Disord. 2024. Retraction in: BMC Cardiovasc Disord. 2025 Feb 18;25(1):112. doi: 10.1186/s12872-025-04554-6. PMID: 39702045 Free PMC article. Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
